Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Actually & more acurately $10.97 per share is a conservative value

RE: Actually & more acurately $10.97 per share is a conservative value

posted on Apr 20, 2006 07:09AM
We used almost all the NOL carry-forward in the nine months just ended. You are implying that millions more in future earnings are going to continue to be tax-free and I do not believe that is correct per the following from the 10-Q:

During the nine months ended February 28, 2006, the Company utilized approximately $33,400,000 of its available Federal net operating loss carry-forwards to offset its taxable income arising during the nine month period ended February 28, 2006. At February 28, 2006 and May 31, 2005 a valuation allowance of approximately $2,100,000 and $14,700,000, respectively, which amounts are equal to the Company’s net deferred tax assets at those dates, has been recorded, as management has not determined that it is more likely than not that the benefit from the deferred tax asset will be realized.

Best

Share
New Message
Please login to post a reply